International Journal of Multiple Sclerosis and Related Disorders

Jorge Matias-Guiu, Hospital Clinico San Carlos,
Madrid,
Institute of Neurociencias,
Director
Editorial Board

Jorge Matias-Guiu

Hospital Clinico San Carlos, Madrid, Institute of Neurociencias, Director · Spain

Editorial leadership for International Journal of Multiple Sclerosis and Related Disorders

Research interests

  • Multiple Sclerosis Neurodegeneratives Diseases

Biography

  1. News in multiple sclerosis: Remyelination as a therapeutic target.Med Clin (Barc). 2016 Dec 3. pii: S0025-7753(16)30530-9. doi: 10.1016/j.medcli.2016.10.021.
  2. Immununochemical Markers of the Amyloid Cascade in the Hippocampus in Motor Neuron Diseases.Front Neurol. 2016 Nov 8;7:195.
  3. Analysis of the Relationship between the Month of Birth and Risk of Multiple Sclerosis in a Spanish Population.Eur Neurol. 2016;76(5-6):202-209.
  4. Vitamin D and remyelination in multiple sclerosis.Neurologia. 2016 Jun 16. pii: S0213-4853(16)30065-2. doi: 10.1016/j.nrl.2016.05.001.
  5. Pittsburgh compound B and other amyloid positron emission tomography tracers for the study of white matter and multiple sclerosis.Ann Neurol. 2016 Jul;80(1):166
  6. Amyloid Proteins and Their Role in Multiple Sclerosis. Considerations in the Use of Amyloid-PET Imaging.Front Neurol. 2016 Mar 31;7:53.
  7. Amyloid PET imaging in multiple sclerosis: an (18)F-florbetaben study.BMC Neurol. 2015 Nov 25;15:243. doi: 10.1186/s12883-015-0502-2.

Considering JSC for your work?

This journal is guided by Jorge Matias-Guiu (Hospital Clinico San Carlos, Madrid, Institute of Neurociencias, Director) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.

Start your submission

Menu